EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Automated free speech analysis reveals distinct markers of Alzheimer’s and frontotemporal dementia

Pamela Lopes da Cunha, Fabián Ruiz, Franco Ferrante, Lucas Federico Sterpin, Agustín Ibáñez, Andrea Slachevsky, Diana Matallana, Ángela Martínez, Eugenia Hesse, Adolfo M García iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Pamela Lopes da Cunha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cognitive Neuroscience Center, Universidad de San Andrés, Victoria, Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Alzheimer Disease, Speech. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Global Brain Health Institute, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dementia can disrupt how people experience and describe events as well as their own role in them. Alzheimer’s disease (AD) compromises the processing of entities expressed by nouns, while behavioral variant frontotemporal dementia (bvFTD) entails a depersonalized perspective with increased third-person references. Yet, no study has examined whether these patterns can be captured in connected speech via natural language processing tools. To tackle such gaps, we asked 96 participants (32 AD patients, 32 bvFTD patients, 32 healthy controls) to narrate a typical day of their lives and calculated the proportion of nouns, verbs, and first- or third-person markers (via part-of-speech and morphological tagging). We also extracted objective properties (frequency, phonological neighborhood, length, semantic variability) from each content word. In our main study (with 21 AD patients, 21 bvFTD patients, and 21 healthy controls), we used inferential statistics and machine learning for group-level and subject-level discrimination. The above linguistic features were correlated with patients’ scores in tests of general cognitive status and executive functions. We found that, compared with HCs, (i) AD (but not bvFTD) patients produced significantly fewer nouns, (ii) bvFTD (but not AD) patients used significantly more third-person markers, and (iii) both patient groups produced more frequent words. Machine learning analyses showed that these features identified individuals with AD and bvFTD (AUC = 0.71). A generalizability test, with a model trained on the entire main study sample and tested on hold-out samples (11 AD patients, 11 bvFTD patients, 11 healthy controls), showed even better performance, with AUCs of 0.76 and 0.83 for AD and bvFTD, respectively. No linguistic feature was significantly correlated with cognitive test scores in either patient group. These results suggest that specific cognitive traits of each disorder can be captured automatically in connected speech, favoring interpretability for enhanced syndrome characterization, diagnosis, and monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaAlzheimer DiseaseSpeechHumansFemaleMaleAgedMiddle AgedCase-Control StudiesBiomarkersNatural Language ProcessingMachine LearningNeuropsychological TestsExecutive Function

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Cognitive Neuroscience Center, Universidad de San Andrés, Victoria, Buenos Aires, Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
  • Facultad de Ingeniería, Universidad de Buenos Aires (FIUBA), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
  • Latin American Brain Health (BrainLat) Institute, Universidad Adolfo Ibáñez, Santiago, Peñalolén, Región Metropolitana, Chile.
  • Global Brain Health Institute, University of California San Francisco, San Francisco, California, United States of America.
  • Trinity College Dublin, Dublin, Ireland.

ORCID-Profile: Adolfo M García

Förderung

  • NIA NIH HHS
  • Global Brain Health Institute
  • National Institute on Aging
  • Agencia Nacional de Investigación y Desarrollo
  • Alzheimer's Association
  • Latin American Brain Health Institute
  • Universidad de Santiago de Chile
  • Takeda Pharmaceuticals U.S.A.

Zitieren

APA

Lopes da Cunha, P., Ruiz, F., Ferrante, F., Sterpin, L. F., Ibáñez, A., Slachevsky, A., Matallana, D., Martínez, Á., Hesse, E., & García, A. M. (2024). Automated free speech analysis reveals distinct markers of Alzheimer’s and frontotemporal dementia. PLOS ONE. https://doi.org/10.1371/journal.pone.0304272

Vancouver

Lopes da Cunha P, Ruiz F, Ferrante F, Sterpin LF, Ibáñez A, Slachevsky A, et al. Automated free speech analysis reveals distinct markers of Alzheimer’s and frontotemporal dementia. PLOS ONE. 2024. doi:10.1371/journal.pone.0304272

BibTeX
@article{LopesdaCunha2024,
  author = {Lopes da Cunha, Pamela and Ruiz, Fabián and Ferrante, Franco and Sterpin, Lucas Federico and Ibáñez, Agustín and Slachevsky, Andrea and Matallana, Diana and Martínez, Ángela and Hesse, Eugenia and García, Adolfo M},
  title = {Automated free speech analysis reveals distinct markers of Alzheimer’s and frontotemporal dementia},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304272}
}
Kostenlos starten →